Investigate the Effect of EPITACT® Light Legs Therapeutic Insoles on the Symptoms and Quality of Life of Patients With Chronic Venous Disease

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

February 11, 2024

Study Completion Date

March 31, 2024

Conditions
Venous DiseaseQuality of LifeSymptoms and Signs
Interventions
DEVICE

Insoles

"At the D0 visit, if the patient is assigned to the arm with insoles.~The patient completes the quality of life and symptom evaluation questionnaires, the plesthysmographic evaluation test, the analysis of walking without insoles and the oedema measurement.~Then, at D30, the patient repeated the same tests, with the exception of the gait and plesthysmographic evaluation tests.~The patient then switched to the other arm."

OTHER

Without insoles

"At the D0 visit, if the patient is assigned to the arm without insoles.~The patient completes the quality of life and symptom evaluation questionnaires, the plesthysmographic evaluation test, the analysis of walking without insoles and the oedema measurement.~Then, at D30, the patient repeated the same tests, with the exception of the gait and plesthysmographic evaluation tests.~The patient then switched to the other arm."

Trial Locations (1)

39100

Centre Hospitalier Louis Pasteur, Dole

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Millet Innovation

INDUSTRY

NCT06620120 - Investigate the Effect of EPITACT® Light Legs Therapeutic Insoles on the Symptoms and Quality of Life of Patients With Chronic Venous Disease | Biotech Hunter | Biotech Hunter